“The professional services offered by MabPlex, their technical ability and customer-oriented service makes me look forward to continuing our ongoing collaboration. As part of our collaboration we expect to obtain FDA IND approval for additional investigational agents in the near future continuing our ongoing collaboration.”
Dayao Zhao
Chief Executive Officer, Encure Biopharma
News
May 1, 2025
January 20, 2025
November 25, 2024